Ruffo Frank

Avg. Two Year Performance

(93%) Avg. Purchase Return
(39%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return4%11%(21%)(62%)(93%)
Purchase Success Rate2 of 21 of 20 of 20 of 20 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

Aclaris Therapeutics, Inc.

Other » Other

Chief Financial Officer:

Holdings: 201.88K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--